TruAlt Bioenergy

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE0MWH01014
  • NSEID: TRUALT
  • BSEID: 544545
INR
477.25
-0.95 (-0.2%)
BSENSE

May 21

BSE+NSE Vol: 1.32 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: TruAlt Bioenergy will declare its result soon on 22 May 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.32 lacs (1.82%) Volume

Shareholding (Mar 2026)

FII

0.66%

Held by 11 FIIs

DII

9.40%

Held by 9 DIIs

Promoter

70.55%

Are TruAlt Bioenergy Ltd latest results good or bad?

04-Feb-2026

TruAlt Bioenergy Ltd's latest results show impressive revenue growth of 520.96% and a return to profitability, but declining operating and profit margins, along with a year-on-year net profit drop of 7.79%, raise concerns about sustainability. Investors should be cautious due to these mixed signals and the company's elevated debt levels.

TruAlt Bioenergy Ltd's latest results present a mixed picture. On one hand, the company achieved a remarkable quarter-on-quarter revenue growth of 520.96%, reaching ₹713.24 crores, and returned to profitability with a net profit of ₹69.33 crores, marking a significant increase of 282.74% compared to the previous quarter. This indicates strong operational momentum and recovery in demand.<BR><BR>However, the profitability metrics reveal concerning trends. The operating margin has compressed significantly from 30.01% in the same quarter last year to 18.79% this year, and the profit after tax (PAT) margin has also declined from 18.11% to 9.70%. This suggests that while the company is generating more revenue, it is struggling to maintain profitability due to rising costs or operational inefficiencies.<BR><BR>Additionally, the year-on-year comparison shows a decline in net profit by 7.79%, which raises concerns about the sustainability of the recent growth. The company's elevated debt levels and weak interest coverage ratio further complicate its financial health.<BR><BR>In summary, while the revenue growth is impressive and indicates a recovery, the significant margin compression and declining profitability metrics suggest that the results are not entirely favorable. Investors should be cautious and monitor how the company addresses these challenges moving forward.

View full answer

Should I buy, sell or hold TruAlt Bioenergy Ltd?

31-Mar-2026

When is the next results date for TruAlt Bioenergy Ltd?

20-May-2026

The next results date for TruAlt Bioenergy Ltd is 22 May 2026.

The next results date for TruAlt Bioenergy Ltd is scheduled for 22 May 2026.

View full answer

Why is TruAlt Bioenergy Ltd falling/rising?

21-May-2026

As of 20-May, TruAlt Bioenergy Ltd's stock price is rising to 478.10, reflecting a 3.57% increase. This growth is driven by strong recent performance, outpacing the benchmark Sensex, and favorable valuation metrics despite some concerns about declining investor participation.

As of 20-May, TruAlt Bioenergy Ltd's stock price is rising, currently at 478.10, which reflects a change of 16.5 or 3.57% increase. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 3.25% compared to the Sensex's 0.95%. In the last month, the stock has risen by 4.37%, while the Sensex has declined by 4.08%. Year-to-date, TruAlt Bioenergy has shown a significant increase of 18.27%, contrasting with the Sensex's drop of 11.62%.<BR><BR>Today's performance indicates that the stock has outperformed its sector by 3.66% and has experienced consecutive gains over the last two days, accumulating a total return of 7.78% during this period. The stock also reached an intraday high of Rs 480.1, marking a 4.01% increase. Furthermore, TruAlt Bioenergy is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive indicator of its price momentum.<BR><BR>Despite some concerns regarding falling investor participation, as evidenced by a 20.24% decrease in delivery volume compared to the 5-day average, the stock remains liquid enough for trading. Additionally, the company has an attractive valuation with a return on capital employed (ROCE) of 8.9 and a significant profit increase of 342% over the past year, although it has reported losses and negative ROCE recently.<BR><BR>In summary, the combination of strong recent performance, positive returns relative to the benchmark, and attractive valuation metrics contribute to the rising stock price of TruAlt Bioenergy Ltd.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Debt company with Weak Long Term Fundamental Strength

  • The company is Net-Debt Free
  • The company has reported losses. Due to this company has reported negative ROCE
2

Flat results in Dec 25

3

36.85% of Promoter Shares are Pledged

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 4,093 Cr (Small Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

43

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.89

stock-summary
Return on Equity

10.11%

stock-summary
Price to Book

2.96

Revenue and Profits:
Net Sales:
713 Cr
(Quarterly Results - Dec 2025)
Net Profit:
69 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
16.57%
0%
16.57%
6 Months
6.32%
0%
6.32%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

TruAlt Bioenergy for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
1.28
Debt to EBITDA (avg)
5.14
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.64
Tax Ratio
7.58%
Dividend Payout Ratio
0
Pledged Shares
36.85%
Institutional Holding
10.07%
ROCE (avg)
8.87%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
28
Industry P/E
43
Price to Book Value
2.96
EV to EBIT
23.00
EV to EBITDA
18.00
EV to Capital Employed
2.04
EV to Sales
2.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.87%
ROE (Latest)
10.11%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

36.8532

Mutual Funds

Held by 5 Schemes (6.7%)

FIIs

Held by 11 FIIs (0.66%)

Promoter with highest holding

Vijaykumar Nirani (17.88%)

Highest Public shareholder

Rakeshkumar Viththalbhai Patel (3.82%)

Individual Investors Holdings

13.5%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "703.02",
          "val2": "104.48",
          "chgp": "572.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "129.05",
          "val2": "-11.79",
          "chgp": "1,194.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "39.65",
          "val2": "38.01",
          "chgp": "4.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "66.02",
          "val2": "-42.75",
          "chgp": "254.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.36%",
          "val2": "-11.28%",
          "chgp": "29.64%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398.41",
          "val2": "573.53",
          "chgp": "-30.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.10",
          "val2": "27.23",
          "chgp": "-15.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.26",
          "val2": "67.15",
          "chgp": "12.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-42.72",
          "val2": "-41.99",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.80%",
          "val2": "4.75%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,101.43",
          "val2": "980.84",
          "chgp": "12.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "152.15",
          "val2": "146.27",
          "chgp": "4.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "114.91",
          "val2": "102.57",
          "chgp": "12.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "23.30",
          "val2": "30.39",
          "chgp": "-23.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.81%",
          "val2": "14.91%",
          "chgp": "-1.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,880.12",
          "val2": "1,223.40",
          "chgp": "53.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "297.20",
          "val2": "188.08",
          "chgp": "58.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "141.04",
          "val2": "143.08",
          "chgp": "-1.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "140.62",
          "val2": "31.81",
          "chgp": "342.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.81%",
          "val2": "15.37%",
          "chgp": "0.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
703.02
104.48
572.88%
Operating Profit (PBDIT) excl Other Income
129.05
-11.79
1,194.57%
Interest
39.65
38.01
4.31%
Exceptional Items
0.00
0.00
Standalone Net Profit
66.02
-42.75
254.43%
Operating Profit Margin (Excl OI)
18.36%
-11.28%
29.64%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
398.41
573.53
-30.53%
Operating Profit (PBDIT) excl Other Income
23.10
27.23
-15.17%
Interest
75.26
67.15
12.08%
Exceptional Items
0.00
0.00
Standalone Net Profit
-42.72
-41.99
-1.74%
Operating Profit Margin (Excl OI)
5.80%
4.75%
1.05%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,101.43
980.84
12.29%
Operating Profit (PBDIT) excl Other Income
152.15
146.27
4.02%
Interest
114.91
102.57
12.03%
Exceptional Items
0.00
0.00
Standalone Net Profit
23.30
30.39
-23.33%
Operating Profit Margin (Excl OI)
13.81%
14.91%
-1.10%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
1,880.12
1,223.40
53.68%
Operating Profit (PBDIT) excl Other Income
297.20
188.08
58.02%
Interest
141.04
143.08
-1.43%
Exceptional Items
0.00
0.00
Standalone Net Profit
140.62
31.81
342.06%
Operating Profit Margin (Excl OI)
15.81%
15.37%
0.44%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About TruAlt Bioenergy Ltd stock-summary
stock-summary
TruAlt Bioenergy Ltd
Small Cap
Commodity Chemicals
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available